Human cytomegalovirus-specific T-cell responses and immune-guided strategies as predictors of clinically significant infection in hematopoietic stem cell transplant recipients after letermovir prophylaxis.

Prevymis (letermovir) - Merck (MSD)

Human cytomegalovirus-specific T-cell responses and immune-guided strategies as predictors of clinically significant infection in hematopoietic stem cell transplant recipients after letermovir prophylaxis. (PubMed, Bone Marrow Transplant) - Jan 8, 2026 - No abstract available
Journal • Bone Marrow Transplantation • Cytomegalovirus Infection • Infectious Disease • Transplantation

http://www.ncbi.nlm.nih.gov/pubmed/41501398

Antonio Bianchessi; Dalila Mele; Daniele Lilleri; Domenico Russo; Elizabeth Iskandar; Fausto Baldanti; Federica Zavaglio; Giulia Grassia; Gloria Vaira; Irene Cassaniti; Irene Defrancesco; Michele Malagola; Nicola Polverelli; Valentina Zoboli

Jan 8, 2026